Literature DB >> 19297485

Prion protein glycosylation is not required for strain-specific neurotropism.

Justin R Piro1, Brent T Harris, Koren Nishina, Claudio Soto, Rodrigo Morales, Judy R Rees, Surachai Supattapone.   

Abstract

In this study, we tested the hypothesis that the glycosylation of the pathogenic isoform of the prion protein (PrP(Sc)) might encode the selective neurotropism of prion strains. We prepared unglycosylated cellular prion protein (PrP(C)) substrate molecules from normal mouse brain by treatment with PNGase F and used reconstituted serial protein cyclic misfolding amplification reactions to produce RML and 301C mouse prions containing unglycosylated PrP(Sc) molecules. Both RML- and 301C-derived prions containing unglycosylated PrP(Sc) molecules were infectious to wild-type mice, and neuropathological analysis showed that mice inoculated with these samples maintained strain-specific patterns of PrP(Sc) deposition and neuronal vacuolation. These results show that PrP(Sc) glycosylation is not necessary for strain-dependent prion neurotropism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19297485      PMCID: PMC2681931          DOI: 10.1128/JVI.02502-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids.

Authors:  Eric M Jones; Witold K Surewicz
Journal:  Cell       Date:  2005-04-08       Impact factor: 41.582

2.  Dichotomous versus palm-type mechanisms of lateral assembly of amyloid fibrils.

Authors:  Natallia Makarava; Olga V Bocharova; Vadim V Salnikov; Leonid Breydo; Maighdlin Anderson; Ilia V Baskakov
Journal:  Protein Sci       Date:  2006-06       Impact factor: 6.725

3.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.

Authors:  J Collinge; K C Sidle; J Meads; J Ironside; A F Hill
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

4.  PrPc glycoform heterogeneity as a function of brain region: implications for selective targeting of neurons by prion strains.

Authors:  S J DeArmond; Y Qiu; H Sànchez; P R Spilman; A Ninchak-Casey; D Alonso; V Daggett
Journal:  J Neuropathol Exp Neurol       Date:  1999-09       Impact factor: 3.685

5.  Mechanism of cross-species prion transmission: an infectious conformation compatible with two highly divergent yeast prion proteins.

Authors:  Motomasa Tanaka; Peter Chien; Koji Yonekura; Jonathan S Weissman
Journal:  Cell       Date:  2005-04-08       Impact factor: 41.582

Review 6.  Human prion diseases: molecular and clinical aspects.

Authors:  Markus Glatzel; Katharina Stoeck; Harald Seeger; Thorsten Lührs; Adriano Aguzzi
Journal:  Arch Neurol       Date:  2005-04

7.  Transmissible spongiform encephalopathy strain, PrP genotype and brain region all affect the degree of glycosylation of PrPSc.

Authors:  Robert A Somerville; Scott Hamilton; Karen Fernie
Journal:  J Gen Virol       Date:  2005-01       Impact factor: 3.891

8.  In vitro generation of infectious scrapie prions.

Authors:  Joaquín Castilla; Paula Saá; Claudio Hetz; Claudio Soto
Journal:  Cell       Date:  2005-04-22       Impact factor: 41.582

9.  Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions.

Authors:  Nathan R Deleault; James C Geoghegan; Koren Nishina; Richard Kascsak; R Anthony Williamson; Surachai Supattapone
Journal:  J Biol Chem       Date:  2005-05-24       Impact factor: 5.157

10.  Selective neuronal targeting in prion disease.

Authors:  S J DeArmond; H Sánchez; F Yehiely; Y Qiu; A Ninchak-Casey; V Daggett; A P Camerino; J Cayetano; M Rogers; D Groth; M Torchia; P Tremblay; M R Scott; F E Cohen; S B Prusiner
Journal:  Neuron       Date:  1997-12       Impact factor: 17.173

View more
  36 in total

Review 1.  Prions on the move.

Authors:  Charles Weissmann; Jiali Li; Sukhvir P Mahal; Shawn Browning
Journal:  EMBO Rep       Date:  2011-10-28       Impact factor: 8.807

2.  Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions.

Authors:  Nathan R Deleault; Daniel J Walsh; Justin R Piro; Fei Wang; Xinhe Wang; Jiyan Ma; Judy R Rees; Surachai Supattapone
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-18       Impact factor: 11.205

Review 3.  Elucidating the role of cofactors in mammalian prion propagation.

Authors:  Surachai Supattapone
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

4.  Underglycosylated prion protein modulates plaque formation in the brain.

Authors:  Jason C Bartz
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

5.  Design and construction of diverse mammalian prion strains.

Authors:  David W Colby; Kurt Giles; Giuseppe Legname; Holger Wille; Ilia V Baskakov; Stephen J DeArmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-13       Impact factor: 11.205

6.  Role of Prion Replication in the Strain-dependent Brain Regional Distribution of Prions.

Authors:  Ping Ping Hu; Rodrigo Morales; Claudia Duran-Aniotz; Ines Moreno-Gonzalez; Uffaf Khan; Claudio Soto
Journal:  J Biol Chem       Date:  2016-04-07       Impact factor: 5.157

7.  Selective amplification of classical and atypical prions using modified protein misfolding cyclic amplification.

Authors:  Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  J Biol Chem       Date:  2012-11-20       Impact factor: 5.157

Review 8.  Synthesis of high titer infectious prions with cofactor molecules.

Authors:  Surachai Supattapone
Journal:  J Biol Chem       Date:  2014-05-23       Impact factor: 5.157

Review 9.  Cofactor molecules: Essential partners for infectious prions.

Authors:  Surachai Supattapone
Journal:  Prog Mol Biol Transl Sci       Date:  2020-08-24       Impact factor: 3.622

10.  Species and strain glycosylation patterns of PrPSc.

Authors:  Konstantinos Xanthopoulos; Magdalini Polymenidou; Sue J Bellworthy; Sylvie L Benestad; Theodoros Sklaviadis
Journal:  PLoS One       Date:  2009-05-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.